OrbiMed Advisors LLC's Form 4 filing
Electra Therapeutics, Inc.ETRA · filed Nov 5, 2026
- Accession no.
- 0000947871-26-000985
- Filed
- Nov 5, 2026, 5:39 PM ET
- Trade date
- Nov 3-5, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 10 non-derivative transactions. Open-market purchases total $3.61M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| OrbiMed Advisors LLCCIK 0001055951 | Director, 10% Owner |
| OrbiMed Capital GP VII LLCCIK 0001760648 | Director, 10% Owner |
| OrbiMed Genesis GP LLCCIK 0001808744 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 3, 2026 | Common Stock | PPurchaseAcquired | +24,313 | $7.84 | +$190,613.92 | 5,151,204 | Indirect | |
| Nov 3, 2026 | Common Stock | PPurchaseAcquired | +97,800 | $7.84 | +$766,752 | 1,856,079 | Indirect | |
| Nov 3, 2026 | Common Stock | PPurchaseAcquired | +24,400 | $7.88 | +$192,272 | 5,175,604 | Indirect | |
| Nov 3, 2026 | Common Stock | PPurchaseAcquired | +98,600 | $7.88 | +$776,968 | 1,954,679 | Indirect | |
| Nov 4, 2026 | Common Stock | PPurchaseAcquired | +9,267 | $7.78 | +$72,097.26 | 5,184,871 | Indirect | |
| Nov 4, 2026 | Common Stock | PPurchaseAcquired | +37,100 | $7.78 | +$288,638 | 1,991,779 | Indirect | |
| Nov 4, 2026 | Common Stock | PPurchaseAcquired | +5,000 | $7.07 | +$35,350 | 5,189,871 | Indirect | |
| Nov 4, 2026 | Common Stock | PPurchaseAcquired | +20,000 | $7.07 | +$141,400 | 2,011,779 | Indirect | |
| Nov 5, 2026 | Common Stock | PPurchaseAcquired | +30,891 | $7.31 | +$225,813.21 | 5,220,762 | Indirect | |
| Nov 5, 2026 | Common Stock | PPurchaseAcquired | +125,200 | $7.31 | +$915,212 | 2,136,979 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.